Analgesics in Singapore

Value sales of analgesics are rising in Singapore in 2025, boosted by strong consumer awareness and a wide product range. Local consumers demonstrate a growing understanding of the uses and differences among analgesics like ibuprofen and naproxen, while demand for trusted branded options remains resilient. Value growth continues to be driven by well-established names such as Panadol, which benefits from heavy advertising and an expanding portfolio targeting various pain relief needs.

This Analgesics in Singapore report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2025, allowing you to identify the sectors driving growth. Forecasts to 2030 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Analgesics market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.